| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $155,234,327 ) (Continued on the next page) |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AI180610 | Enhancing memory T cell defense in the female reproductive tract. | 001 | 1 | NIH | 11/20/2023 | $0 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F30ES036439 | Investigating Determinants of Perinatal Lead Exposure, Associations with Preterm Birth, and Reporting Back Research Results in the Atlanta African American Maternal Child Cohort | 000 | 1 | NIH | 4/15/2024 | $55,194 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R33HL163743 | Small Molecule Therapeutics for Sickle Cell Anemia | 000 | 2 | NIH | 2/15/2024 | $489,553 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R13EB035927 | fNIRS2024 Birmingham | 000 | 1 | NIH | 3/22/2024 | $3,000 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R13EB035927 | fNIRS2024 Birmingham | 000 | 1 | NIH | 3/22/2024 | $10,000 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI182244 | Immunometabolic Biomarkers to Advance TB Diagnosis and Treatment Monitoring | 000 | 1 | NIH | 4/15/2024 | $664,496 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DE033433 | Targeted Arf1 inhibition to enhance immune response in oral cancer | 000 | 1 | NIH | 2/14/2024 | $371,905 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DE033691 | Inhibiting mitochondrial complex I to improve cetuximab efficacy in oral cancer | 000 | 1 | NIH | 2/22/2024 | $386,463 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI179463 | The Role of Immunoglobulin Genetic Diversity in the Development of Neutralizing Antibodies Against HIV Env Protein | 001 | 1 | NIH | 2/23/2024 | $0 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI179463 | The Role of Immunoglobulin Genetic Diversity in the Development of Neutralizing Antibodies Against HIV Env Protein | 000 | 1 | NIH | 2/23/2024 | $47,694 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K99ES036289 | Mapping the cosmetic chemical exposome and its role in female fertility | 000 | 1 | NIH | 4/15/2024 | $128,358 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AR080869 | MRI of Tendon Structure and Metabolism | 000 | 2 | NIH | 4/18/2024 | $185,922 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21NS132393 | Fascin in brain development and function | 001 | 2 | NIH | 4/9/2024 | $0 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21NS132393 | Fascin in brain development and function | 000 | 2 | NIH | 3/13/2024 | $188,935 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA272991 | Real-time Volumetric Imaging for Motion Management and Dose Delivery Verification | 001 | 2 | NIH | 4/17/2024 | $25,505 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA272991 | Real-time Volumetric Imaging for Motion Management and Dose Delivery Verification | 000 | 2 | NIH | 4/3/2024 | $459,124 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21EY035136 | Atypical opsins and the OIR model of retinopathy of prematurity | 001 | 2 | NIH | 4/25/2024 | $195,625 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21NS133960 | Mechanistic insights of cortical hyperexcitability in ALS | 000 | 1 | NIH | 1/26/2024 | $75,699 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AI176944 | Primary cell culture models of HIV/HBV co-infection | 000 | 1 | NIH | 4/2/2024 | $21,207 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | K23HL173694 | Advancing Approaches to Identify Young Children at Risk for Post-Discharge Mortality | 000 | 1 | NIH | 3/27/2024 | $196,155 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | K01ES035082 | Cumulative effects of persistent organic pollutants and non-chemical stressors on child development | 000 | 1 | NIH | 3/15/2024 | $160,679 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K01MH136861 | The role of monocyte metabolism and migration in inflammation-related reward circuit deficits and symptoms of anhedonia in people with HIV | 000 | 1 | NIH | 4/22/2024 | $146,986 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01HL171735 | Advancing Symptom Science and Management in Cystic Fibrosis: Biological, Social, and Clinical Mechanisms | 000 | 1 | NIH | 12/15/2023 | $590,820 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI176717 | Evaluating the Influence of an Improved Piped Water Network on Water Quality and Gut Microbiome Composition Among Children in Mozambique | 001 | 1 | NIH | 3/27/2024 | $0 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI176717 | Evaluating the Influence of an Improved Piped Water Network on Water Quality and Gut Microbiome Composition Among Children in Mozambique | 000 | 1 | NIH | 3/27/2024 | $50,194 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | U24HL171672 | The Georgia Cystic Fibrosis Data Warehouse | 000 | 1 | NIH | 2/28/2024 | $783,577 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R37MH117103 | Integrated mechanisms for orbitofrontal cortical control of memory and choice | 000 | 6 | NIH | 11/15/2023 | $608,117 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R37MH117103 | Integrated mechanisms for orbitofrontal cortical control of memory and choice | 001 | 6 | NIH | 2/22/2024 | $608,117 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R37MH117103 | Integrated mechanisms for orbitofrontal cortical control of memory and choice | 001 | 6 | NIH | 2/22/2024 | -$608,117 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS134941 | The Pallidohabenular System in Parkinsonism | 000 | 1 | NIH | 1/4/2024 | $704,153 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R03MH135518 | Fragile X messenger ribonucleoprotein-1 mediated regulation of the Clathrin-Associated Adaptor Complex Protein-2 (AP2) | 000 | 1 | NIH | 12/22/2023 | $156,500 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31NR020848 | The Influence of Symptoms, Functional Status, and Social Vulnerability on Healthcare Use Among Patients Receiving Dialysis | 000 | 1 | NIH | 3/1/2024 | $47,694 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK136023 | Developing statistical analysis and prediction tools for continuous glucose monitoring (CGM) use in hospitalized patients with diabetes | 000 | 1 | NIH | 2/5/2024 | $370,716 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES035738 | The Omics and Mixtures Integration on Traffic exposure and Preterm Birth (OMIT-PTB) Study | 000 | 1 | NIH | 4/23/2024 | $654,756 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R03AG087436 | Targeting Excitability in Alzheimer's Disease | 000 | 1 | NIH | 4/3/2024 | $307,230 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG085587 | Deciphering the IgG glycosylation code of Alzheimer's Disease | 000 | 1 | NIH | 1/23/2024 | $561,681 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AI178324 | Multiomics Characterization of Micobiome and Immunometabolic REmodeling in Tuberculosis Stress Hyperglycemia | 000 | 1 | NIH | 4/1/2024 | $176,063 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK138366 | Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) | 000 | 1 | NIH | 3/27/2024 | $744,361 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI184167 | Developing Virus like Particles for HIV-1 Cure Strategy | 000 | 1 | NIH | 4/9/2024 | $47,694 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31HL168949 | Roles for integrins in control of lung barrier function | 001 | 1 | NIH | 11/20/2023 | $0 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U24ES028528 | The Michigan PBB Cohort: A unique, highly exposed community followed for 50 years and three generations | 000 | 6 | NIH | 4/4/2024 | $390,260 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31HL168949 | Roles for integrins in control of lung barrier function | 000 | 1 | NIH | 11/20/2023 | $47,694 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM153472 | DNA nanodevices for molecular interrogation and regulation of lymphocytes in adaptive immune system | 000 | 1 | NIH | 3/27/2024 | $391,250 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21HL173513 | Defining immune pathways involved in the formation of antibodies against factor VIII | 000 | 1 | NIH | 3/14/2024 | $117,375 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R36MH136806 | Mitochondrial Defects in 22q11.2 Deletion Using a Human-Derived Neuronal Stem Cell Model | 000 | 1 | NIH | 3/8/2024 | $40,964 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA284386 | Targeting hTERT/telomerase for managing acquired resistance to third generation EGFR-TKIs in lung cancer | 000 | 1 | NIH | 4/5/2024 | $433,505 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01HL169373 | Molecular mechanisms relating Poldip2 to endothelial permeability | 001 | 1 | NIH | 4/3/2024 | $0 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01HL169373 | Molecular mechanisms relating Poldip2 to endothelial permeability | 000 | 1 | NIH | 3/8/2024 | $705,011 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R00HL161355 | Accumulation of stress and trauma across the life course and cardiometabolic risk during pregnancy and postpartum | 000 | 3 | NIH | 2/2/2024 | $248,999 |
|